Metanomics Health GmbH - Product Pipeline Analysis, 2016 Update - New Report Available

From: Fast Market Research, Inc.
Published: Thu May 05 2016

Metanomics Health GmbH (Metanomics), a subsidiary of BASF SE, is a metabolite profiling company that focuses on metabolic biomarker identification and validation. The analysis of metabolites provides crucial information for various applications in pharma and biotech, biobanking, academia, the food and feed industry and diagnostics fields. It develops novel biomarkers for diagnostic applications in conditions such as early asymptomatic heart failure and type-2 diabetes. The company's products include MxP Broad Profiling, MxP Targeted Profiling, MxP Isotope Tracer, MetaMap Tox and MxP Quality Control Plasma. It employs fully validated methods to analyze eicosanoic acid, catecholamines, steroids, energy metabolites and lipids. The company out-licenses new metabolic biomarkers to CLIA lab and diagnostic partners. It has operations in Japan and the US. Metanomics is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

Full Report Details at

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


* The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
* The report analyzes all pipeline products in development for the company Metanomics Health GmbH
* The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
* The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
* The report provides detailed description of products in development, technical specification and functions
* The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
* Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
* To formulate effective Research & Development strategies
* Develop market-entry and market expansion strategies
* Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Siemens Healthcare GmbH - Product Pipeline Analysis, 2016 Update
- Novian Health, Inc. - Product Pipeline Analysis, 2016 Update
- Agilent Technologies, Inc. (A) - Product Pipeline Analysis, 2016 Update
- OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update
- miacom diagnostics GmbH - Product Pipeline Analysis, 2015 Update

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »